Search by Drug Name or NDC

    NDC 63824-0201-44 Mucinex Sinus-Max 325; 200; 5 mg/1; mg/1; mg/1 Details

    Mucinex Sinus-Max 325; 200; 5 mg/1; mg/1; mg/1

    Mucinex Sinus-Max is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63824-0201
    Product ID 63824-201_0b529799-dc16-0fb8-e063-6294a90aa61f
    Associated GPIs 43996703500310
    GCN Sequence Number 060554
    GCN Sequence Number Description guaifen/phenyleph/acetaminophn TABLET 200-5-325 ORAL
    HIC3 B3N
    HIC3 Description DECONGESTANT-ANALGESIC-EXPECTORANT COMBINATION
    GCN 26743
    HICL Sequence Number 023719
    HICL Sequence Number Description GUAIFENESIN/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Mucinex Sinus-Max
    Proprietary Name Suffix Severe Congestion Relief
    Non-Proprietary Name Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 63824-0201-44 (63824020144)

    NDC Package Code 63824-201-44
    Billing NDC 63824020144
    Package 4 POUCH in 1 CARTON (63824-201-44) / 2 TABLET, COATED in 1 POUCH (63824-201-72)
    Marketing Start Date 2012-07-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.52908
    Pricing Unit EA
    Effective Date 2021-06-23
    NDC Description MUCINEX SINUS-MAX SEVERE CPLT
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 6
    Classification for Rate Setting B
    As of Date 2022-06-15
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis